Tag: Thrive Capital

Browse our exclusive articles!

OpenAI Faces Uncertainty as CEO Firing & Executive Departures Threaten $86B Valuation

Planned sale of OpenAI employee shares at risk amid CEO firing and executive departures, potentially impacting startup's $86B valuation - The Information report.

Insights from Benchmark’s Conversation with Miles Grimshaw on the Artificial Intelligence Race

Miles Grimshaw, the newest addition to venture firm Benchmark, led a seed round in LangChain, a SaaS development firm focused on large language models. While Grimshaw recognizes the potential of generative AI, he advised against investments when model depreciation rates undermine ROI. Benchmark focuses on being the most impactful partner to founders and invests in one to two deals yearly.

Essential Information About OpenAI’s $300M Stock Offering

. OpenAI, a leading non-profit and renegade AI startup has reportedly confirmed a $300 million share sale, valuing it between $27 and $29 billion. Investors include Tiger Global Management, Andreessen Horowitz, and Sequoia Capital, plus Thrive Capital and K2 Global. OpenAI has revolutionized the tech sector with its AI breakthroughs such as its chatbot GPT-3 and robotics engineering, leading the industry to revenues of over $18 billion in 2021.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img